Arrepath Announces $20 Million Seed Financing To Advance Its Machine Learning-Based Platform For Discovery Of Novel Anti-Infectives Addressing Antimicrobial Resistance
Amount Raised
$20 Million
Round Type
Seed
PrincetonInformation TechnologySoftwareData And AnalyticsScience And EngineeringDescription
ArrePath, an anti-infective drug discovery company addressing the global health challenge of drug resistant infections, announced today that it has raised $20 million in seed financing to advance its proprietary, machine learning (ML)-based platform for the discovery of new classes of anti-infectives to overcome antimicrobial resistance (AMR). The Boehringer Ingelheim Venture Fund, Insight Partners, and Innospark Ventures co-led the financing, which also included Viva BioInnovator, Arimed Capital, PTX Capital, and Nor’easter Ventures.
Quick answer
ArrePath raised $20 Million in a Seed round, dated March 3, 2022. ArrePath is based in Princeton, New Jersey, United States.
- How much did ArrePath raise?
- ArrePath raised $20 Million in a Seed round on March 3, 2022.
- What does ArrePath do?
- ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel..
- Where is ArrePath based and how big is it?
- ArrePath is based in Princeton, New Jersey, United States.
- Who are the decision-makers at ArrePath?
- Fundz holds 1 contact at ArrePath. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as ArrePath that raised within 45 days of this round, from Fundz verified event records.
- Be Biopharma raised $130M (Funding Round) on April 14, 2022.
- PassiveLogic raised $15M (Funding Round) on April 12, 2022.
- Lilt raised $55M (Series C) on April 7, 2022.
- Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
- Conversica raised $25M (Funding Round) on April 5, 2022.
- Clarify Health raised $150M (Series D) on April 5, 2022.
Who to call at ArrePath, and when
A new round usually means ArrePath is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ArrePath raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ArrePath, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ArrePath. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ArrePath raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ArrePath raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.